Gynecologic Oncology Associates   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: CA United States

Organization Overview

First Clinical Trial
2004
NCT00127920
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now